National and Kapodistrian University of Athens
Η κλινική σημασία της έκφρασης των πρωτεϊνών FAK, Src, Paxillin στο νεφροκυτταρικό καρκίνο
Abstract
dc:descriptionBackground: Renal cell carcinoma (RCC) is the third most common cancer of the urinary tract. Research on protein expression and Src kinase cascade have revealed valuable targets for therapeutics in renal cancer. The FAK/Src complex and its downstream target, Paxillin, seem to play a significant role in malignant transformation, tumor growth, tumor invasion, and metastasis. Objective: This study aimed to evaluate the expression of FAK, Src, and Paxillin in RCC patients regarding the positivity, intensity, and immunoreactive score (IRS) and to relate them with clinical parameters. Methods: We included patients with suspicious malignant features in the kidney from the First Department of Urology (Laiko) of the National and Kapodistrian University of Athens who underwent partial or radical nephrectomy. FAK, Src, and Paxillin immunohistochemical expression in formalin-fixed paraffin-embedded tumor tissue were analyzed and associated with clinicopathological qualities. Results: 90 patients (70% male), with a mean age of 59.96 (SD 12.96) years, enrolled in the study. 58 (64.4%) patients had clear cell RCC (ccRCC), 15 (16.7%) papillary RCC, 11 (12.2%) chromophobe and 6 had unclassified RCC. FAK, Src, and Paxillin were detected in 55.6%, 32.2%, and 18.9% of all patients. Univariate analysis showed that FAK positivity and IRS were expressed more in patients with papillary and chromophobe RCC than in patients with clear cell RCC. Moreover, Src positivity and IRS were more frequently expressed in the T3 stage when compared to the T1, whereas Paxillin positivity was expressed more in the T3 stage than in the T2 and in grades 3-4, compared to grade 2. Finally, women were 4.2 times more likely to have Paxillin detected in their specimens despite their low numbers in the sample. Conclusion: This study shows that FAK, Src, and Paxillin are immunohistochemically expressed in renal cell cancer specimens, with varying expression levels. Evidence implies that the histologic RCC type, cancer stage, nuclear grade, and gender may influence this expression. These findings confirm the results from previous studies manifesting an involvement of the FAK/Src signaling pathway in the pathogenesis of RCC. Future studies will shed light on possible therapeutic or prognostic targets in the management of renal cancer.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mitsos, Panagiotis
- Μήτσος, Παναγιώτης
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/57110